Safety and Quality-of-Life Data from an Italian Expanded Access Program of Lenvatinib for Treatment of Thyroid Cancer.
Giani C, Valerio L, Bongiovanni A, Durante C, Grani G, Ibrahim T, Mariotti S, Massa M, Pani F, Pellegriti G, Porcelli T, Salvatore D, Tavarelli M, Torlontano M, Locati L, Molinaro E, Elisei R.
Giani C, et al. Among authors: tavarelli m.
Thyroid. 2021 Feb;31(2):224-232. doi: 10.1089/thy.2020.0276. Epub 2020 Oct 22.
Thyroid. 2021.
PMID: 32907501